Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation

Authors

Yu Jing

Published

May 31, 2024

Abstract

The intricate molecular mechanisms underlying estrogen receptor-positive (ER

Supporters

Support the authors with ResearchCoin

Journal

Life Sciences

Topics

DOI

10.1016/j.lfs.2024.122763

Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation

Authors

Yu Jing

Published

May 31, 2024

Abstract

The intricate molecular mechanisms underlying estrogen receptor-positive (ER

Supporters

Support the authors with ResearchCoin

Journal

Life Sciences

Topics

DOI

10.1016/j.lfs.2024.122763

Paper

Paper

Paper

Paper

Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation

Abstract

Supporters

Journal

Topics

DOI

Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation

Abstract

Supporters

Journal

Topics

DOI